Cargando…
Resveratrol inhibits lipid accumulation in the intestine of atherosclerotic mice and macrophages
Disordered intestinal metabolism is highly correlated with atherosclerotic diseases. Resveratrol protects against atherosclerotic diseases. Accordingly, this study aims to discover novel intestinal proatherosclerotic metabolites and potential therapeutic targets related to the anti‐atherosclerotic e...
Autores principales: | Ye, Guozhu, Chen, Guoyou, Gao, Han, Lin, Yi, Liao, Xu, Zhang, Han, Liu, Xinyu, Chi, Yulang, Huang, Qiansheng, Zhu, Huimin, Fan, Yuhua, Dong, Sijun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6533483/ https://www.ncbi.nlm.nih.gov/pubmed/30957417 http://dx.doi.org/10.1111/jcmm.14323 |
Ejemplares similares
-
PPARα and PPARγ activation attenuates total free fatty acid and triglyceride accumulation in macrophages via the inhibition of Fatp1 expression
por: Ye, Guozhu, et al.
Publicado: (2019) -
Metabolomics approach reveals metabolic disorders and potential biomarkers associated with the developmental toxicity of tetrabromobisphenol A and tetrachlorobisphenol A
por: Ye, Guozhu, et al.
Publicado: (2016) -
Fine particulate matter 2.5 exerted its toxicological effect by regulating a new layer, long non-coding RNA
por: Huang, Qiansheng, et al.
Publicado: (2017) -
DPPC-coated lipid nanoparticles as an inhalable carrier for accumulation of resveratrol in the pulmonary vasculature, a new strategy for pulmonary arterial hypertension treatment
por: Li, Zerong, et al.
Publicado: (2020) -
A Lipid-Structured Model of Atherosclerotic Plaque Macrophages with Lipid-Dependent Kinetics
por: Watson, Michael G., et al.
Publicado: (2023)